1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: Acacia Pharma Group plc
1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify)iii:
3. Details of person subject to the notification obligationiv
Name Cosmo Pharmaceuticals N.V.
City and country of registered office (if applicable) Riverside 2, Sir John Rogerson’s Quay, Dublin 2, Ireland
4. Full name of shareholder(s) (if different from 3.)v
Name Cosmo Technologies Ltd.
City and country of registered office (if applicable) Riverside 2, Sir John Rogerson’s Quay, Dublin 2, Ireland
5. Date on which the threshold was crossed or reachedvi: 10/01/2020
6. Date on which issuer notified (DD/MM/YYYY): 13/01/2020
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8. A) % of voting rights through financial instruments
(total of 8.B 1 + 8.B 2) Total of both in % (8.A + 8.B) Total number of voting rights of issuervii
Resulting situation on the date on which threshold was crossed or reached 14.08% - 14.08% 63,882,865
Position of previous notification (if
applicable) - - -